HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Pascale Schumann-Bard Selected Research
Pascale Schumann-Bard Research Topics
Disease
5
Stroke (Strokes)
09/2012 - 02/2007
5
Hypoxia (Hypoxemia)
04/2012 - 04/2002
5
Ischemia
10/2009 - 01/2006
4
Brain Ischemia (Cerebral Ischemia)
10/2009 - 04/2002
2
Cognitive Dysfunction
10/2021 - 01/2020
1
Drug-Related Side Effects and Adverse Reactions
10/2021
1
Pain (Aches)
10/2021
1
Neuroinflammatory Diseases
09/2012
Drug/Important Bio-Agent (IBA)
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2012 - 04/2002
4
Erythropoietin
FDA Link
10/2009 - 04/2002
3
Oxygen (Dioxygen)
IBA
10/2009 - 01/2006
2
Messenger RNA (mRNA)
IBA
04/2012 - 04/2002
2
Adrenomedullin
IBA
04/2012 - 10/2009
2
Glucose (Dextrose)
FDA Link
Generic
10/2009 - 04/2006
2
Proteins (Proteins, Gene)
FDA Link
04/2006 - 04/2002
1
Analgesics (Analgesic Drugs)
IBA
10/2021
1
Tramadol (K315)
FDA Link
Generic
10/2021
1
Muscarinic Antagonists
IBA
01/2020
1
Cholinergic Antagonists (Anticholinergics)
IBA
01/2020
1
Nerve Growth Factors (Neurotrophins)
IBA
09/2012
1
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
09/2012
1
Neurotransmitter Agents (Neurotransmitter)
IBA
09/2012
1
Antidepressive Agents (Antidepressants)
IBA
09/2012
1
Recombinant Proteins
IBA
10/2009
1
Neuroprotective Agents
IBA
10/2009
1
Deferoxamine (Desferal)
FDA Link
Generic
04/2006
1
Chelating Agents
IBA
04/2006
1
Iron
IBA
04/2006
1
Oligonucleotides
IBA
01/2006
Therapy/Procedure
4
Therapeutics
09/2012 - 02/2007
1
Ischemic Postconditioning
10/2009
1
Intravenous Injections
09/2008